Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42)
| Jurisdiction: | Federal |
| Incentive Type: | Grant Program |
| Industries: | Medical |
| Eligible Sector: | Business |
| Category: | Financial Incentive |
| Time Period: | FY 2015 |
| Governing Body: | National Institutes of Health |
| What’s it worth?: | Not mentioned |
Administered by The National Institute of Mental Health (NIMH) of The National Institutes of Health (NIH). It is a Small Business Innovation Technology Transfer Research (STTR) grant opportunity (PA-14-196) for small business concerns (SBCs) — with no more than 500 employees — to develop technologies to advance translational, clinical, and neuroscience research on mental disorders; and to promote evidence-based mental health care.
Maximum funding is generally $150,000 for Phase 1 of the research project and $1,000,000 for Phase 2, with the potential for 50% more (up to $225,000 in Phase 1 and $1,500,000 in Phase 2) or even higher if the additional funding is determined to be justified or necessary.
